Click Chemistry Selectively Activates an Auristatin Protodrug with either Intratumoral or Systemic Tumor-Targeting Agents

نویسندگان

چکیده

The Click Activated Protodrugs Against Cancer (CAPAC) platform enables the activation of powerful cancer drugs at tumors. CAPAC utilizes a click chemistry reaction between tetrazine and trans-cyclooctene. activator, linked to tumor-targeting agent, protodrug leads targeted drug. Here, tumor targeting is achieved by intratumoral injection tetrazine-modified hyaluronate (SQL70) or infusion HER2-targeting antigen-binding fragment (SQT01). Monomethyl auristatin E (a cytotoxin hindered in its clinical use severe toxicity) was modified with trans-cyclooctene form SQP22, which reduced cytotoxicity vitro vivo. Treatment SQP22 paired SQL70 demonstrated antitumor effects Karpas 299 RENCA murine models, establishing requirement for activation. SQT01 induced HER2-positive NCI-N87 xenograft model, showing that tumor-targeted could be accomplished via systemic dosing. Observed toxicities were limited, transient myelosuppression moderate body weight loss detected. This study highlights capabilities demonstrating activity two differentiated approaches underscores power precisely control

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

In vivo targeting through click chemistry.

Targeting small molecules to diseased tissues as therapy or diagnosis is a significant challenge in drug delivery. Drug-eluting devices implanted during invasive surgery allow the controlled presentation of drugs at the disease site, but cannot be modified once the surgery is complete. We demonstrate that bioorthogonal click chemistry can be used to target circulating small molecules to hydroge...

متن کامل

In vivo tumor cell targeting with "click" nanoparticles.

The in vivo fate of nanomaterials strongly determines their biomedical efficacy. Accordingly, much effort has been invested into the development of library screening methods to select targeting ligands for a diversity of sites in vivo. Still, broad application of chemical and biological screens to the in vivo targeting of nanomaterials requires ligand attachment chemistries that are generalizab...

متن کامل

The pharmacologic basis for antibody-auristatin conjugate activity.

Antibody-drug conjugates (ADCs) made with auristatin antimitotic agents have shown significant preclinical and clinical oncology activity. SGN-75 is composed of the anti-CD70 antibody h1F6 conjugated to monomethylauristatin F through a noncleavable maleimidocaproyl linkage. To understand the pharmacologic basis of the activity of this ADC, its pharmacokinetics and biodistribution were evaluated...

متن کامل

Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction.

Recent preclinical studies have suggested that radiotherapy in combination with antiangiogenic/vasculature targeting agents enhances the therapeutic ratio of ionizing radiation alone. Because radiotherapy is one of the most widely used treatments for cancer, it is important to understand how best to use these two modalities to aid in the design of rational patient protocols. The mechanisms of i...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: ACS central science

سال: 2023

ISSN: ['2374-7951', '2374-7943']

DOI: https://doi.org/10.1021/acscentsci.3c00365